The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

12 Jun 2013 07:00

RNS Number : 8300G
Sopheon PLC
12 June 2013
 



 

SOPHEON PLC

 

AGM Statement

 

At the Annual General Meeting of Sopheon plc to be held later today, the chairman of the board will give shareholders an update and review of the business. This will include the following statement:

 

"We were delighted to report strong growth in 2012 with revenues up by 23% to £12.7m, as well as improvement in profits, with EBITDA growing to £1.8m from £1.5m and profit before tax growing to £281,000 from £104,000. We also strengthened the Group's working capital position by extending the maturity and level of our convertible debt, having paid down the majority of our term loan with BlueCrest Capital. In addition, we shifted our Amsterdam listing from Euronext to Alternext, an exciting market that is a better match for our corporate profile.

 

At the end of 2011 we noted that our strong client base was absorbing much attention from our sales team, resulting in less focus on generating new accounts. We therefore reorganized to drive more balanced attention to both new account acquisition and generating additional growth out of our client base, and this was reflected in a much better performance from new accounts last year. This improvement was underpinned by a major contribution from customers headquartered in new territories such as China and the Middle East. We also saw early fruits of our shift to an agile development methodology with a number of customer-focused releases, culminating in the landmark release of Accolade 8.2 at the start of 2013.

 

On the back of the operating and corporate improvements described above, we ended last year with the confidence to expand headcount in targeted areas of the business, and we have kept shareholders updated on our recruitment activities over recent months. These resources are driving accelerated initiatives for expanded regional sales and marketing, digital marketing programs and product development releases, as well as supplementing our services capacity. This has been achieved through a mix of new hires and fairly extensive subcontracting activity, in part to provide specific skill-sets not yet available from our in house resources. Full year 2013 revenue visibility from contracted business and recurring revenue streams has now risen above £8m, compared to £7.5m at the time of our AGM statement a year ago. This improvement, much of which is represented by services, is encouraging. However, our cost expansion is being undertaken in conjunction with higher internal revenue goals. We are currently working to close a considerable amount of license business, some of which is needed in June to enable first half revenues to exceed the comparable 2012 result.

 

Over the past year we have advised shareholders of our plans to undertake a capital reorganization to consolidate the number of shares and shareholders, and to reduce the accumulated deficit on the profit and loss account. These proposals were formalized and notified to shareholders in a circular dated 1 May, which is available on the Company's website. The proposals will be put to shareholders in a general meeting of the Company, to be held immediately after today's Annual General Meeting."

 

For further information contact:

 

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte Stranner / Victoria Bates

finnCap

+ 44 (0) 20 7600 1658

Heather Armstrong/ Josh Royston

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, and portfolio and in-market management. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Alternext Exchange in the Netherlands. For more information, please visit www.sopheon.com

 

Revenue visibility is defined in Note4 of Sopheon's 2012 annual report which is available from the investor section of www.sopheon.com .

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLFFEFRIILLIV
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.